CYBERMED LIFE - ORGANIC  & NATURAL LIVING

Art Therapy

Art therapy improved depression and influenced fatigue levels in cancer patients on chemotherapy.

Written by CYBERMED LIFE NEWS
facebook Share on Facebook
Abstract Title:

Art therapy improved depression and influenced fatigue levels in cancer patients on chemotherapy.

Abstract Source:

Psychooncology. 2007 Nov ;16(11):980-4. PMID: 17351987

Abstract Author(s):

Gil Bar-Sela, Lily Atid, Sara Danos, Naomi Gabay, Ron Epelbaum

Article Affiliation:

Gil Bar-Sela

Abstract:

INTRODUCTION: Cancer patients are particularly vulnerable to depression and anxiety, with fatigue as the most prevalent symptom of those undergoing treatment. The purpose of this study was to determine whether improvement in depression, anxiety or fatigue during chemotherapy following anthroposophy art therapy intervention is substantial enough to warrant a controlled trial.

MATERIAL AND METHODS: Sixty cancer patients on chemotherapy and willing to participate in once-weekly art therapy sessions (painting with water-based paints) were accrued for the study. Nineteen patients who participated in>or =4 sessions were evaluated as the intervention group, and 41 patients who participated in

RESULTS: BFI scores were higher in the participant group (p=0.06). In the intervention group, the median HADS score for depression was 9 at the beginning and 7 after the fourth appointment (p=0.021). The median BFI score changed from 5.7 to 4.1 (p=0.24). The anxiety score was in the normal range from the beginning.

CONCLUSION: Anthroposophical art therapy is worthy of further study in the treatment of cancer patients with depression or fatigue during chemotherapy treatment.


We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.